| Ytd | -31.12% | |
| 1y | -57.97% |
| Open | 29.45 | Prev Close | 29.38 | Low | 29.16 | High | 30.50 | Mkt Cap | 5.44B |
| Vol | 4.94M | Avg Vol | 4.44M | EPS | 0.85 | P/E | 35.88 | Forward P/E | 19.58 |
| Beta | 1.22 | Short Ratio | 4.63 | Inst. Own | 102.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 25.66 | 200-d Avg | 26.48 | 1yr Est | 29.67 |
DOCS News
New York, New York--(Newsfile Corp. - October 10, 2026) - WHY: Rosen Law Firm, a global investor rig
NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
New York, New York--(Newsfile Corp. - October 9, 2026) - WHY: Rosen Law Firm, a global investor righ
New York, New York--(Newsfile Corp. - October 8, 2026) - Kaplan Fox & Kilsheimer LLP announces that
On October 08, 2026, Doximity Inc (DOCS) shares rose 6.1% today, trading at $29.38, which is signifi
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS LawPR Newsw
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor righ
LOS ANGELES, Oct. 8, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold
New class action for Doximity (DOCS) urges investors to seek recovery for alleged securities fraud v
Promise versus reality: Doximity told investors its Newsfeed was driving record engagement and growt
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
New York, New York--(Newsfile Corp. - October 7, 2026) - Robbins Geller Rudman & Dowd LLP announces
LOS ANGELES, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o
BENSALEM, Pa., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors th
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitPR NewswireNEW YORK,
NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, remin
NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
Disclosure under scrutiny: the securities action challenges whether Doximity's public assurances tha
New York, New York--(Newsfile Corp. - October 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
Alert: Claims focus on alleged misrepresentations about Doximity's revenue growth and market share a
LOS ANGELES, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shar
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
New York, New York--(Newsfile Corp. - October 5, 2026) - WHY: Rosen Law Firm, a global investor righ
The latest trading day saw Doximity (DOCS) settling at $28.58, representing a +2.33% change from its
LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors o
DOCS' rapid clinical AI adoption and strong cash generation support its outlook, but tight pharma bu
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announ
Important notice regarding alleged Newsfeed revenue misrepresentations: the lawsuit contends Doximit
New class action for Doximity (DOCS) urges investors to seek recovery for alleged securities fraud v
NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit
LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national sharehold
New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor righ
New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Oct. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
Evercore ISI Group analyst Elizabeth Anderson maintains Doximity (NYSE:DOCS) with a In-Line and l
Freedom Capital Markets analyst Gene Mannheimer downgrades Doximity (NYSE:DOCS) from Buy to Hold
Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises th
Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, w
Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:DOCS) with a Hold and raises t
Wells Fargo analyst Stan Berenshteyn downgrades Doximity (NYSE:DOCS) from Equal-Weight to Underwe
U.S. stocks rose, Nasdaq Composite up 1%. Natera Inc (NTRA) shares jump 20.5% after strong Q2 result
US stocks higher, Nasdaq up 300 pts. Dow +0.3%, Nasdaq +1.2%, S&P 500 +0.58%. Materials and Doxi
Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare
Doximity beat Q1 revenue estimates, raised fiscal 2027 sales guidance and highlighted strong AI adop
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.
JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:DOCS) with a Neutral and raises the pri
Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:DOCS) with a Overweight and raises
U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose,